Story perspectives

Gene Editing Shows Promise in Tackling High Cholesterol

2/12/2026

Summary

Story summary

Researchers are pursuing a gene-editing treatment as a potential one-time solution for high cholesterol.
Early gene-editing studies show promise, with participants experiencing significant reductions in low-density lipoprotein cholesterol.
Two companies, including Verve Therapeutics, are conducting trials in several countries, and United States sites are planned.
Experts emphasize the need for further research to address safety and long-term effects.
The American Heart Association recommends lifestyle changes and medications to manage cholesterol.

1 of 1

Story summary

Researchers are pursuing a gene-editing treatment as a potential one-time solution for high cholesterol.
Early gene-editing studies show promise, with participants experiencing significant reductions in low-density lipoprotein cholesterol.
Two companies, including Verve Therapeutics, are conducting trials in several countries, and United States sites are planned.
Experts emphasize the need for further research to address safety and long-term effects.
The American Heart Association recommends lifestyle changes and medications to manage cholesterol.